Site of Collection Segment Analysis: Submandibular/Sublingual Gland Collection (Largest Segment) vs Parotid Gland Collection (Fastest-Growing Segment)

Submandibular/Sublingual gland collection accounted for the largest share of the saliva collection and diagnostics market, representing 52.15% in 2026, supported by the substantial contribution of these glands to overall saliva production and their established relevance in non-invasive sample collection. Saliva obtained from these sites can provide useful biological material for diagnostic analysis while avoiding many of the challenges associated with blood-based sampling. Growing interest in minimally invasive diagnostics, patient-friendly specimen collection, and decentralized testing is encouraging healthcare providers and diagnostic developers to expand saliva-based approaches. The practicality of collecting samples from the submandibular and sublingual regions, together with increasing research into salivary biomarkers, reinforces their established role in diagnostic workflows.

Parotid gland collection is expected to be the fastest-growing segment, driven by increasing interest in gland-specific saliva sampling and its potential value in specialized diagnostic and research applications. More targeted collection approaches can support investigations into biomarkers associated with oral and systemic conditions while providing opportunities to improve the specificity of saliva-based analysis. Advances in collection techniques and growing scientific interest in understanding gland-specific salivary composition are creating additional opportunities for parotid sampling. As diagnostic development increasingly focuses on non-invasive and biomarker-driven approaches, the use of parotid gland collection is positioned to gain greater attention.

Application Segment Analysis: Disease Diagnostics (Largest Segment) vs Forensic Applications (Fastest-Growing Segment)

Disease diagnostics dominated the saliva collection and diagnostics market, accounting for 86.07% in 2026, reflecting the expanding use of saliva as a non-invasive source of biomarkers for identifying and monitoring health conditions. Saliva collection offers advantages including easier sampling, reduced patient discomfort, and suitability for settings where conventional specimen collection may be less convenient. Increasing research into salivary biomarkers and the development of diagnostic methods capable of detecting clinically relevant indicators are supporting broader adoption. The growing emphasis on accessible, patient-friendly testing is further strengthening the role of saliva-based diagnostics across healthcare applications.

Forensic applications are projected to experience the fastest growth as saliva provides a convenient biological specimen for identifying individuals and supporting investigative analysis. The ability to collect samples through relatively simple, non-invasive procedures can be valuable in situations where rapid and practical biological evidence collection is required. Improvements in molecular analysis and specimen handling are also enhancing the utility of saliva in forensic workflows. As forensic professionals increasingly adopt analytical approaches that can extract reliable information from readily obtainable biological samples, demand for saliva collection and diagnostic technologies in forensic applications is expected to expand.